Candida auris in Europe: Epidemiology and antifungal resistance. A systematic review
Journal of the European Academy of Dermatology and Venereology · 17.07.2026
DOI: 10.1111/jdv.70600 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, online erschienen am 17.07.2026. Verfasst von Carmen Rodríguez-Cerdeira und 14 weiteren Autor:innen. Beteiligte Einrichtung: Fundación Vithas, Grupo Hospitalario Vithas, Madrid, Spain. Die Arbeit nennt 91 Literaturangaben.
Abstract (Originalsprache)
Background
Candida auris is a widely distributed yeast that is considered a dangerous pathogen, with reported mortality rates ranging from 30% to 60%. This yeast shows a high level of resistance to several antifungal agents commonly used to treat systemic infections. The pathogen persists on contaminated surfaces, tolerates hospital‐grade disinfectants, survives desiccation and spreads easily through direct or indirect contact. It has been reported on all five continents and is increasingly prevalent in Europe.
Objective
To determine the distribution and antifungal susceptibility/resistance of Candida auris isolates identified in Europe until January 2025.
Methods
This systematic review followed the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) guidelines. Searches were conducted in EBSCOhost, MEDLINE/PubMed, Scopus and SciELO databases using the terms ‘ Candida auris ’ and ‘ Candidozyma auris ’, combined with the name of each European country. It was limited to English or Spanish articles published until 31 January 2025, excluding reviews, meta‐analyses and book chapters.
Results
Ninety‐one articles reporting antifungal susceptibility were retrieved, covering 2191 clinical isolates of C. auris from 16 countries. Most isolates were from Spain ( n = 886, 40.44%), Italy ( n = 553, 25.24%), Greece ( n = 214, 9.77%), the United Kingdom ( n = 182, 8.31%) and Russia ( n = 108, 4.93%), accounting for 88.68% of cases. The remaining 248 isolates (11.32%) were reported across 11 other countries. Fluconazole resistance was found in 90.51% (1555/1718), while resistance to amphotericin B and echinocandins was 13.17% (223/1693) and 4.57% (76/1693), respectively.
Conclusions
Candida auris has been predominantly detected in Southern Europe, where the majority of clinical isolates exhibit resistance to fluconazole. Consensus is essential for timely diagnosis, targeted treatment and infection control to prevent its spread. New therapeutic options must be explored to manage Candida auris .
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Fundación Vithas, Grupo Hospitalario Vithas, Madrid, Spain.
- Department of Dermatology, Grupo Hospitalario (CMQ-Concheiro), Vigo, Spain.
- Department of Health Sciences, University of Vigo, Vigo, Spain.
- Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Ciudad de México, Mexico.
- Department of Allergy, Dermatology and Venereology, Copenhagen University Hospital, Herlev and Gentofte, Denmark.
- Department of Clinical Medicine, Faculty of Health & Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
ORCID-Profile: Carmen Rodríguez-Cerdeira, Erick Martínez-Herrera, Ditte M L Saunte, Jacek Szepietowski, Rodolfo Pinto-Almazán
Zitieren
APA
Rodríguez-Cerdeira, C., Martínez-Herrera, E., Saunte, D. M. L., Vite-Garín, T., Fuentes-Venado, C. E., Hay, R., Zárate-Segura, P. B., Szepietowski, J., Prohic, A., Arabatzis, M., Sergeev, A., Padovese, V., Skerlev, M., Pinto-Almazán, R., & Mycology Task Force Group of the EADV (2026). Candida auris in Europe: Epidemiology and antifungal resistance. A systematic review. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.70600
Vancouver
Rodríguez-Cerdeira C, Martínez-Herrera E, Saunte DML, Vite-Garín T, Fuentes-Venado CE, Hay R, et al. Candida auris in Europe: Epidemiology and antifungal resistance. A systematic review. Journal of the European Academy of Dermatology and Venereology. 2026. doi:10.1111/jdv.70600
BibTeX
@article{RodrguezCerdeira2026,
author = {Rodríguez-Cerdeira, Carmen and Martínez-Herrera, Erick and Saunte, Ditte M L and Vite-Garín, Tania and Fuentes-Venado, Claudia Erika and Hay, Roderick and Zárate-Segura, Paola Berenice and Szepietowski, Jacek and Prohic, Asja and Arabatzis, Michael and Sergeev, Alexey and Padovese, Valeska and Skerlev, Mihael and Pinto-Almazán, Rodolfo and Mycology Task Force Group of the EADV, Mycology Task Force Group of the EADV},
title = {Candida auris in Europe: Epidemiology and antifungal resistance. A systematic review},
journal = {Journal of the European Academy of Dermatology and Venereology},
year = {2026},
doi = {10.1111/jdv.70600}
}
EUVIMED